Medical research and development contract army sttr PH II A2-9117 titled long-term malarial chemoprophylactic drug releasing implant. Topic A18B-T002

Ended Definitive Contract Awarded Last action

Contract number
W81XWH22C0023
Awardee
Awarding agency
Obligated
$999,995

Award facts

Opportunity
  • HQ003421RAAST Solicitation number
Contract value 100% obligated
$999,994.61 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 5 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Charlottesville, VA, USA
Research
STTR Phase II

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00003 · Army sttr PH II A2-9117 (months 13-23) $0
Supplemental Agreement for work within scope P00002 · Army sttr PH II A2-9117 medical research and development contract army sttr PH II A2-9117 titled long-term malarial chemoprophylactic drug releasing implant.… $0
Funding Only Action P00001 · Per section 711 of the 2019 ndaa, usarmaa transferred to DHA 10/1/2022. Medical research and development contract army sttr PH II A2-9117 titled long-term… $559,995
Original award $440,000

About this award

This is a $999,994.61 firm-fixed-price Small Business Technology Transfer (STTR) Phase II contract awarded by the Defense Health Agency to Luna Labs USA LLC, a division of Luna Innovations Incorporated, for the development of a long-term malarial chemoprophylactic drug-releasing implant. The contract is titled "MEDICAL RESEARCH AND DEVELOPMENT CONTRACT ARMY STTR PH II A2-9117 TITLED LONG-TERM MALARIAL CHEMOPROPHYLACTIC DRUG RELEASING IMPLANT" and is set to be completed by October 31, 2024. Luna Labs USA LLC, a small business entity, is the prime contractor for this research and development effort, which aims to address the critical need for improved malaria prevention solutions for military personnel and other at-risk populations.

Quick answers

Who was awarded contract W81XWH22C0023?

W81XWH22C0023 was awarded to Luna Labs USA LLC by Defense Health Agency (Department of Defense) on March 10, 2022.

How much is contract W81XWH22C0023 worth?

The government has obligated $999,995 on W81XWH22C0023.

Was contract W81XWH22C0023 competed?

The extent of competition for W81XWH22C0023 was full and open competition after exclusion of sources. The government received 5 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award